Tiffany Baerwaldt

Tiffany Baerwaldt is a seasoned professional in market access strategy and marketing with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Market Access Strategy & Marketing at Stoke Therapeutics since October 2025, Tiffany previously held similar senior director roles at Ironwood Pharmaceuticals and Provention Bio before its acquisition by Sanofi. Tiffany's career includes leadership positions at Genentech, where responsibilities spanned market access strategy and market analysis. Early career experience includes roles at GfK, PwC, ICON plc, and PriceSpective LLC, focusing on pricing and market access. Tiffany holds a Bachelor of Arts in Environmental Studies and Economics from Emory University and has further education from Queen Mary University of London.